ABCL vs. EXAI

Last updated Jun 4, 2026

ABCL (AbCellera Biologics Inc.) and EXAI (Exscientia Ltd ADR) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. At a 0.30 correlation, their price movements are largely independent.

Performance

ABCL vs. EXAI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AbCellera Biologics Inc. (ABCL) and Exscientia Ltd ADR (EXAI). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

ABCL

• 1D: -6.69%
• 1M: 24.62%
• YTD: 67.25%
• 6M: 63.90%
• 1Y: 147.62%
• 3Y*: -5.56%
• 5Y*: -26.11%
• 10Y*: —

EXAI

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ABCL vs. EXAI - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
ABCL AbCellera Biologics Inc.	67.25%	16.72%	-48.69%	-43.63%	-29.16%	-16.86%
EXAI Exscientia Ltd ADR	0.00%	0.00%	-24.49%	20.26%	-73.03%	-27.08%

Correlation

The correlation between ABCL and EXAI is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (3Y) Calculated over the trailing 3-year period	0.26
Correlation (All Time) Calculated using the full available price history since Oct 4, 2021	0.30

Fundamentals

Total Revenue (TTM) ABCL : $79.21M EXAI : $17.07M
Gross Profit (TTM) ABCL : $70.89M EXAI : -$11.56M
EBITDA (TTM) ABCL : -$166.07M EXAI : -$135.58M

Return for Risk

ABCL vs. EXAI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ABCL

ABCL Risk / Return Rank: 81
ABCL Sharpe Ratio Rank: 87
ABCL Sortino Ratio Rank: 84
ABCL Omega Ratio Rank: 79
ABCL Calmar Ratio Rank: 80
ABCL Martin Ratio Rank: 74

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ABCL vs. EXAI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AbCellera Biologics Inc. (ABCL) and Exscientia Ltd ADR (EXAI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ABCL	EXAI	Difference
Sharpe ratio: Return per unit of total volatility	1.88	—	—
Sortino ratio: Return per unit of downside risk	2.61	—	—
Omega ratio: Gain probability vs. loss probability	1.30	—	—
Calmar ratio: Return relative to maximum drawdown	2.70	—	—
Martin ratio: Return relative to average drawdown	4.94	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	ABCL	EXAI	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.88	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.39	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.50	—	—

Drawdowns

Drawdown Indicators

	ABCL	EXAI	Difference
Max Drawdown Largest peak-to-trough decline	-96.72%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-54.94%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-75.72%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-92.64%	—	—
Current Drawdown Current decline from peak	-90.29%	—	—
Average Drawdown Average peak-to-trough decline	-83.59%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	30.01%	—	—

Volatility

Volatility by Period

	ABCL	EXAI	Difference
Volatility (1M) Calculated over the trailing 1-month period	28.65%	—	—
Volatility (6M) Calculated over the trailing 6-month period	52.34%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	79.56%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	66.48%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	70.07%	—	—

Dividends

ABCL vs. EXAI - Dividend Comparison

Neither ABCL nor EXAI has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ABCL and EXAI in my portfolio?

ABCL and EXAI have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.